FIG 2.

(A) Percent reduction of tumor size per RECIST criteria during treatment with neoadjuvant IVADo chemotherapy among patients with type II and type III PPB. Teal lines represent patients with SD, red lines represent patients with PR, and blue lines represent patients with scans falling outside the established assessment window. (B) Waterfall plot of best response during weeks 5-9 for patients receiving neoadjuvant IVADo chemotherapy, with teal representing SD and red representing PR per RECIST criteria. IVADO, ifosfamide, vincristine, actinomycin-D, and doxorubicin; PPB, pleuropulmonary blastoma; PR, partial response; SD, stable disease.